Skip to Content

TG Therapeutics

TGTX

Buy $TGTX at eToro
Rank 2519
Country USA
Exchange NASDAQ
Currency USD
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address 2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY, US

TG Therapeutics - Key figures

Market cap 626.85 Million
Revenue 7.91 Million
Profit 5.9 Million
P/E Ratio No information
P/s Ratio 79.23
Buy $TGTX at eToro

TG Therapeutics - Description

TG Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases.

The company is headquartered in New York, New York.